Baba Y, Baker M C, Le Ber I, Brice A, Maeck L, Kohlhase J, Yasuda M, Stoppe G, Bugiani O, Sperfeld A D, Tsuboi Y, Uitti R J, Farrer M J, Ghetti B, Hutton M L, Wszolek Z K
Department of Neurology, Mayo Clinic, Jacksonville, Florida 32224, USA.
J Neural Transm (Vienna). 2007 Jul;114(7):947-50. doi: 10.1007/s00702-007-0632-9. Epub 2007 Feb 23.
In 9 patients with frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) with a P301S tau mutation, the predominant phenotype was frontotemporal dementia in 3 and parkinsonism in 6. Comparison of the tau genotype/haplotype carrying the mutation and the initial clinical sign showed association between H1/H1 and parkinsonism and between H1/H2 and personality change. Thus, the tau haplotype carrying the mutation and the tau genotype may be related to the clinical phenotype throughout the disease course.
在9例与17号染色体相关的额颞叶痴呆和帕金森症(FTDP-17)且携带P301S tau突变的患者中,3例主要表现为额颞叶痴呆,6例主要表现为帕金森症。对携带该突变的tau基因型/单倍型与初始临床症状进行比较,结果显示H1/H1与帕金森症、H1/H2与人格改变之间存在关联。因此,携带该突变的tau单倍型和tau基因型可能在疾病全过程中与临床表型相关。